The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 37 | — | 20.1x | Near average | |
Growth | 86 | 7332.8% | 5.6% | Above average | |
Quality | 66 | 52.4% | 7.6% | Near average | |
Safety | 19 | 3.3x | 0.4x | Below average | |
Capital Return | 22 | — | 2.19% | Below average | |
Momentum | 71 | — | — | Above average | |
Sentiment | 48 | — | — | Near average |
Adagene Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Adagene Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Adagene (ADAG) stock has seen remarkable stability in its target price at $5, with a significant development represented by the increase in the number of analysts covering the stock from one analyst to 3 analysts over the past 24 hours. This complete consensus (Dispersion Zero) among the three analysts on the same price target reflects a unified view toward the stock's fair value, reducing uncertainty despite the high-risk nature of the biotechnology sector.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.